Form 4 shows that Christina Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd (IBEX), reported a sale of 844 common shares on 09/16/2025 at a price of $38.50 per share. After the reported transaction she beneficially owns 11,727 shares, held directly. The filing was made as a single reporting person and signed by an attorney-in-fact on 09/17/2025.
IBEX Ltd (Form 144): A proposed sale of 8,114 common shares is notified for sale on 09/16/2025 through Global Shares Financial Services Inc. The filing reports an aggregate market value of $309,467.96 and lists 13,315,077 shares outstanding for the issuer. The shares were originally acquired on 08/07/2020 as a grant from the issuer. The filer also reported a recent sale of 350 shares on 08/26/2025 generating $10,194.36 in gross proceeds. The notice includes the required representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Form 144 notice for IBEX Ltd shows a proposed sale of 45,027 common shares by the person named, with an aggregate market value of $1,751,100.03 and an approximate sale date of 09/16/2025 on NASDAQ. The shares were acquired as a grant on 08/07/2020. The filing also discloses a prior sale by the same person of 1,634 shares on 08/26/2025 for gross proceeds of $47,593.10. The filer certifies they have no undisclosed material adverse information about the issuer and includes the standard Rule 144 attestation language.
Form 144 filed for IBEX Ltd (IBEX) reports a proposed sale of 844 shares of common stock valued at $32,494 with an approximate sale date of 09/16/2025 on NASDAQ. The shares were acquired by the seller as a stock grant from the issuer on 07/01/2025 (1,210 shares acquired in that grant). The filing also discloses a prior disposal by the same person of 366 shares on 08/26/2025 for gross proceeds of $10,660.39. The filer certifies they have no material nonpublic information about the issuer.
Insider sale by IBEX Ltd CFO to satisfy tax withholding from RSU vesting. Taylor C. Greenwald, listed as Chief Financial Officer, reported a sale of 438 common shares on 08/26/2025 at a price of $29.13 per share. The filing states the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units and were not discretionary trades. After the transaction, the reporting person beneficially owned 35,856 shares, held directly. The Form 4 was signed by an attorney-in-fact, Lisa Lenstrohm, on 09/15/2025.
IBEX Ltd. insider sale reported: Paul Joseph Inson, listed as Chief People Officer, reported a sale of 3,831 common shares on 09/12/2025 at a price of $38.94 per share. Following the sale, the filing shows Mr. Inson beneficially owns 3,266 shares. The Form 4 was signed by an attorney-in-fact on 09/15/2025. The document contains no additional explanation of the reason for the sale or any derivative transactions.
Paul Joseph Inson, Chief People Officer of IBEX Ltd (IBEX), reported a sale of shares to satisfy tax-withholding obligations related to vested restricted stock units. The Form 4 shows a sale of 255 common shares on 08/26/2025 at a price of $29.13 per share. After the sale, the reporting person beneficially owns 7,097 shares in a direct ownership form. The filing states the sale was executed to cover tax withholding and not as a discretionary trade by the reporting person. The form was filed individually and was signed by an attorney-in-fact on 09/15/2025.
IBEX Ltd reporting person Julie K. Casteel sold 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding on vested restricted stock units. After the sale the reporting person beneficially owned 30,895 shares, held directly. The Form 4 indicates the sales were required to satisfy tax obligations and were not discretionary trades, signaling they were routine administrative transactions related to equity compensation rather than a change in investment view.
IBEX Ltd insider Christina Alice Trofimuk-O'Connor, identified as the company's Chief Legal Officer and a director, reported a sale of 366 common shares on 08/26/2025 at $29.13 per share. After the transaction she beneficially owned 12,571 shares directly. The filing states the sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. All details above are taken directly from the submitted Form 4.
David Martin Afdahl, Chief Operating Officer of IBEX Ltd (IBEX), reported a non-discretionary sale of 403 common shares on 08/26/2025 at $29.13 per share. The filing states the sale was required to cover tax withholding arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 54,986 common shares directly. The Form 4 was filed as a single-person filing and is signed by an attorney-in-fact.